A biohybrid hydrogel for the urate-responsive release of urate oxidase

Journal of Controlled Release

Volumn 171, Issue 1, 2013, Pages 57-62

  Geraths, Christian ^a   Daoud El Baba, Marie ^b   Charpin El Hamri, Ghislaine ^b   Weber, Wilfried ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

Biohybrid material; Closed loop control; DNA protein interaction; Gouty arthritis; Stimulus sensing material

Indexed keywords

CROSSLINKING; DISEASES; HYDROGELS; MEDICAL APPLICATIONS;

BIOHYBRID MATERIALS; CLOSED-LOOP CONTROL; DNA-PROTEIN INTERACTION; GOUTY ARTHRITIS; SENSING MATERIAL;

ORGANIC ACIDS;

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HUCO; TRANSCRIPTION FACTOR HUCR; UNCLASSIFIED DRUG; URATE OXIDASE; URIC ACID DERIVATIVE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROGEL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS; URIC ACID BLOOD LEVEL;

BIOHYBRID MATERIAL; CLOSED-LOOP CONTROL; DNA-PROTEIN INTERACTION; GOUTY ARTHRITIS; STIMULUS-SENSING MATERIAL;

ANIMALS; DEOXYRIBONUCLEASE I; DRUG DELIVERY SYSTEMS; HEK293 CELLS; HUMANS; HYDROGELS; MICE; POLYETHYLENE GLYCOLS; URATE OXIDASE; URIC ACID;

EID: 84885167679     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.06.037     Document Type: Article

References (24)

1. K. Jakobus, S. Wend, W. Weber, Synthetic mammalian gene networks as a blueprint for the design of interactive biohybrid materials, Chem. Soc. Rev. 41 (2012) 1000-1018.
2. W. Weber, M. Fussenegger, Emerging biomedical applications of synthetic biology, Nat Rev. Genet. 13 (2012) 21-35.
3. R.J. Gubeli, K. Burger, W. Weber, Synthetic biology for mammalian cell technology and materials sciences, Biotechnol. Adv. 31 (2013) 68-78.
4. S.Y. Cheng, I. Constantinidis, A. Sambanis, Use of glucose-responsive material to regulate insulin release from constitutively secreting cells, Biotechnol. Bioeng. 93 (2006) 1079-1088.
5. J.J. Kim, K. Park, Modulated insulin delivery from glucose-sensitive hydrogel dosage forms, J. Control. Release 77 (2001) 39-47. (Pubitemid 33022614)
6. J.D. Ehrick, M.R. Luckett, S. Khatwani, Y.N. Wei, S.K. Deo, LG. Bachas, S. Daunert, Glucose responsive hydrogel networks based on protein recognition, Macromol. Biosci. 9 (2009) 864-868.
7. N.A. Peppas, CD. Bures, Glucose-responsive hydrogels, Encycl. Biomater. Biomed. Eng. 112 (2006) 1163-1173.
8. E.H. Christen, M. Karlsson, M.M. Kampf, R. Schoenmakers, R.J. Gubeli, H.M. Wischhusen, C. Friedrich, M. Fussenegger, W. Weber, Conditional DNA-protein interactions confer stimulus-sensing properties to biohybrid materials, Adv. Funct. Mater. 21 (2011) 2861-2867.
9. C. Geraths, E.H. Christen, W. Weber, A hydrogel sensing pathological urate concentrations, Macromol. Rapid Commun. 33 (2012) 2103-2108.
10. J.L. Ramos, M. Martinez-Bueno, A.J. Molina-Henares, W. Teran, K. Watanabe, X. Zhang, M.T. Gallegos, R. Brennan, R. Tobes, The TetR family of transcriptional re-pressors, Microbiol. Mol. Biol. Rev. 69 (2005) 326-356.
11. W. Hillen, C. Berens, Mechanisms underlying expression of Tn10 encoded tetracy-cline resistance, Annu. Rev. Microbiol. 48 (1994) 345-369. (Pubitemid 24334101)
12. C. Kemmer, M. Gitzinger, M. Daoud-El Baba, V. Djonov, J. Stelling, M. Fussenegger, Self-sufficient control of urate homeostasis in mice by a synthetic circuit, Nat. Biotechnol. 28 (2010) 355-360.
13. J.F. Wilson, In the clinic. Gout, Ann. Intern. Med. 152 (2010) ITC21.
14. P. Richette, T. Bardin, Gout, Lancet 375 (2010) 318-328.
15. F.P. Wilson, J.S. Berns, Onco-nephrology: tumor lysis syndrome, Clin. J. Am. Soc. Nephrol. 7 (2012) 1730-1739.
16. C.C. Weber, N. Link, C. Fux, A.H. Zisch, W. Weber, M. Fussenegger, Broad-spectrum protein biosensors for class-specific detection of antibiotics, Biotechnol. Bioeng. 89 (2005) 9-17. (Pubitemid 40110979)
17. M. Ehrbar, R. Schoenmakers, E.H. Christen, M. Fussenegger, W. Weber, Drug-sensing hydrogels for the inducible release of biopharmaceuticals, Nat. Mater. 7 (2008) 800-804.
18. M.M. Kampf, E.H. Christen, M. Ehrbar, M. Daoud-El Baba, G. Charpin-El Hamri, M. Fussenegger, W. Weber, A gene therapy technology-based biomaterial for the trigger-inducible release of biopharmaceuticals in mice, Adv. Funct. Mater. 20 (2010) 2534-2538.
19. C. Geraths, L. Eichstadter, R.J. Gubeli, E.H. Christen, C. Friedrich, W. Weber, Synthesis and characterization of a stimulus-responsive L-ornithine-degrading hy-drogel, J. Control. Release 165 (2013) 38-43.
20. D. Nadano, T. Yasuda, K. Kishi, Measurement of deoxyribonuclease I activity in human tissues and body fluids by a single radial enzyme-diffusion method, Clin. Chem. 39 (1993) 448-452. (Pubitemid 23099010)
21. D.D. Freitas, P.J. Spencer, R.C. Vassao, J. Abrahao-Neto, Biochemical and bio-pharmaceutical properties of PEGylated uricase, Int. J. Pharm. 387 (2010) 215-222.
22. R.J. Gübeli, D. Hövermann, H. Seitz, B. Rebmann, R.G. Schoenmakers, M. Ehrbar, G. Charpin-El Hamri, M. Daoud-El Baba, M. Werner, M. Müller, W. Weber, Remote-controlled hydrogel depots for time-scheduled vaccination, Adv. Funct. Mater. (2013), http://dx.doi.org/10.1002/adfm. 201300875, (early view publication).
23. L. Baeksgaard, J.B. Sorensen, Acute tumor lysis syndrome in solid tumors - A case report and review of the literature, Cancer Chemother. Pharmacol. 51 (2003) 187-192. (Pubitemid 36469946)
24. G.L. Chen, W. Wei, S.Y. Xu, Effect and mechanism of total saponin of Dioscorea on animal experimental hyperuricemia, Am. J. Chin. Med. 34 (2006) 77-85. (Pubitemid 43231403)